Expanded Use of Vorasidenib in Non-Enhancing Recurrent CNS WHO Grade 3 Oligodendroglioma.
Saved in:
| Title: | Expanded Use of Vorasidenib in Non-Enhancing Recurrent CNS WHO Grade 3 Oligodendroglioma. |
|---|---|
| Authors: | Himstead AS; Department of Neurological Surgery, University of California, Irvine, CA 92697, USA., Chen JW; Department of Neurological Surgery, University of California, Irvine, CA 92697, USA., Chu E; Department of Radiological Sciences, University of California, Irvine, CA 92697, USA., Perez-Rosendahl MA; Department of Pathology & Laboratory Medicine, University of California, Irvine, CA 92697, USA., Zheng M; UC Irvine Charlie Dunlop School of Biological Sciences, University of California, Irvine, CA 92697, USA., Mathew S; Department of Research, University of California, Irvine, CA 92697, USA., Yuen CA; Department of Neurology, Division of Neuro-Oncology, University of California, Irvine, CA 92697, USA. |
| Source: | Biomedicines [Biomedicines] 2025 Jan 15; Vol. 13 (1). Date of Electronic Publication: 2025 Jan 15. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
